Royal Bank of Canada’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-578
Closed -$1K 7422
2020
Q4
$1K Hold
578
﹤0.01% 6924
2020
Q3
$1K Buy
578
+111
+24% +$120 ﹤0.01% 6395
2020
Q2
$0 Buy
+467
New +$333 ﹤0.01% 6623

Other funds holding SRTAW

Royal Bank of Canada's SRTAW Position: Q1 2021 in Review

Royal Bank of Canada sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q1 2021, closing a stake of 578 shares — an estimated $1K sold.

Royal Bank of Canada first reported a position in SRTAW in Q2 2020 and held it in 3 quarters. The position peaked at $1K in Q4 2020. 12 funds tracked by Wall St. Rank hold SRTAW as of Q1 2021.

  • Royal Bank of Canada reported no remaining Strata Critical Medical Inc Warrants position as of Q1 2021 after selling out during the quarter.
  • Royal Bank of Canada sold 578 Strata Critical Medical Inc Warrants shares in Q1 2021, an estimated $1K.
  • Royal Bank of Canada first reported a position in Strata Critical Medical Inc Warrants in Q2 2020 and held it in 3 quarters.
  • Royal Bank of Canada's Strata Critical Medical Inc Warrants position peaked at $1K in Q4 2020.
  • 12 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q1 2021.

Based on Royal Bank of Canada's 13F filing for Q1 2021, filed 17 May 2021.